On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia

Arsenic is generally considered hypertoxic. However, it has been used in traditional Chinese medicine since ancient times, to treat serious illnesses. Recently, a single dose of arsenic trioxide (As2O3) has been found especially effective in treating acute promyelocytic leukemia (APL). Generally spe...

Full description

Bibliographic Details
Main Author:	Peng Zhang
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	Leukemia Research Reports
Subjects:	Arsenic Trioxide Treatment Acute Promyelocytic Leukemia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048917300080

id	doaj-bc5a8645beca4772ad8b58edebc272b8
record_format	Article
spelling	doaj-bc5a8645beca4772ad8b58edebc272b82020-11-24T23:04:27ZengElsevierLeukemia Research Reports2213-04892017-01-017C293210.1016/j.lrr.2017.03.001On arsenic trioxide in the clinical treatment of acute promyelocytic leukemiaPeng ZhangArsenic is generally considered hypertoxic. However, it has been used in traditional Chinese medicine since ancient times, to treat serious illnesses. Recently, a single dose of arsenic trioxide (As2O3) has been found especially effective in treating acute promyelocytic leukemia (APL). Generally speaking, As2O3 is a more effective treatment of APL than other, newer medications and has less severe adverse reactions and greater safety.http://www.sciencedirect.com/science/article/pii/S2213048917300080ArsenicTrioxideTreatmentAcute Promyelocytic Leukemia
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Peng Zhang
spellingShingle	Peng Zhang On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia Leukemia Research Reports Arsenic Trioxide Treatment Acute Promyelocytic Leukemia
author_facet	Peng Zhang
author_sort	Peng Zhang
title	On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
title_short	On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
title_full	On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
title_fullStr	On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
title_full_unstemmed	On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
title_sort	on arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
publisher	Elsevier
series	Leukemia Research Reports
issn	2213-0489
publishDate	2017-01-01
description	Arsenic is generally considered hypertoxic. However, it has been used in traditional Chinese medicine since ancient times, to treat serious illnesses. Recently, a single dose of arsenic trioxide (As2O3) has been found especially effective in treating acute promyelocytic leukemia (APL). Generally speaking, As2O3 is a more effective treatment of APL than other, newer medications and has less severe adverse reactions and greater safety.
topic	Arsenic Trioxide Treatment Acute Promyelocytic Leukemia
url	http://www.sciencedirect.com/science/article/pii/S2213048917300080
work_keys_str_mv	AT pengzhang onarsenictrioxideintheclinicaltreatmentofacutepromyelocyticleukemia
_version_	1725630351033761792

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia

Similar Items